Nordhealth AS - Publication of Information Document
The attached information document has been prepared by Nordhealth AS (the "Company") solely for use in connection with the admission to trading of the Company's class A shares on Euronext Growth Oslo, commencing on 3 June 2021. Carnegie AS has acted as the Company's Euronext Growth Advisor. Advokatfirmaet Thommessen AS has acted as legal counsel to the Company, and Advokatfirmaet Haavind AS has acted as legal counsel to the Euronext Growth Advisor in connection with the admission to trading. For further information, please contact: Charles MacBain, CEO charles.macbain@